TrialNature medicine2022

Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial.

Jesper D Gunst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.